Rebecca S Kaufman

12PUBLICATIONS
154CO-AUTHORS
Molecular targetsBiologically active moleculesCancer geneticsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 16, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

|Feb 16, 2026
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription.

Rebecca Kaufman, Guillermo Flores, Elissa A Boguslawski

|Nov 21, 2025
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric central nervous system tumors.

Ryan J Corbett, Rebecca S Kaufman, Shelly W McQuaid

|Nov 07, 2025
Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma.

Jarrett Lindsay, Jonathan Gaither, David Groff

|Aug 12, 2025
Confounding factors affecting analysis of germline structural variants in pediatric solid tumors.

Pandurang Kolekar, Rebecca S Kaufman, Nadezhda V Terekhanova

|Jul 14, 2025
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.

Marie Ménard, Hiroyuki Yoda, Nicole Nasholm

Pageof 2

Frequent Collaborators

7 joint publications

Sharon J Diskin

5 joint publications

Jo Lynne Rokita

4 joint publications

Elissa A Boguslawski

4 joint publications

Patrick J Grohar